Even clinicians who are not as familiar with these medications will ask me, 'I have a patient on Mounjaro who's not losing weight can we switch to Zepbound? without realizing its exactly the same drug. To complicate matters, pharmaceutical companies are quickly working on new drugs including triple agonists that target GLP-1, GIP and glucagon receptors as well as oral versions of each drug
Our real-time stability studies demonstrate that properly manufactured Retatrutide Powder maintains at least 99.5% purity for 36 months when stored under recommended conditions
Robert Kushner, who helped bring them to market, breaks down how they actually work, who benefits most, and why they're a long-term commitment rather than a quick fix
Key takeaways GLP-1 agonists are a class of drugs that were originally designed to treat type 2 diabetes, but their use has expanded to include weight loss, heart and kidney disease risk reduction, and management of obstructive sleep apnea
GLP-1 receptor agonists are positioned as one of the pharmacotherapeutic options that can contribute to addressing the high unmet medical need characterizing several prevalent aging-related diseases, making them ideal for our longevity-focused approach
Experiment With Food Pairings and Meal Timing It's not just about what you eat - it's also about when you eat
-1775582746855.png&w=384&q=75)
